Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
4(40%)
Results Posted
0%(0 trials)
Terminated
1(10%)

Phase Distribution

Ph not_applicable
8
80%
Ph phase_2
1
10%
Ph phase_4
1
10%

Phase Distribution

0

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution10 total trials
Phase 2Efficacy & side effects
1(10.0%)
Phase 4Post-market surveillance
1(10.0%)
N/ANon-phased studies
8(80.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

4

trials recruiting

Total Trials

10

all time

Status Distribution
Active(4)
Completed(3)
Terminated(1)
Other(2)

Detailed Status

Completed3
unknown2
Recruiting2
Active, not recruiting2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
4
Success Rate
75.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (10.0%)
Phase 41 (10.0%)
N/A8 (80.0%)

Trials by Status

unknown220%
completed330%
recruiting220%
active_not_recruiting220%
terminated110%

Recent Activity

Clinical Trials (10)

Showing 10 of 10 trials

All 10 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
10